Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | Sunitinib | GDSC1000 | pan-cancer | AAC | 0.019 | 0.7 |
mRNA | foretinib | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | TL-1-85 | GDSC1000 | pan-cancer | AAC | 0.01 | 0.7 |
mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |
mRNA | BMS-754807 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.7 |
mRNA | navitoclax:pluripotin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | BRD-K09344309 | CTRPv2 | pan-cancer | AAC | 0.025 | 0.7 |
mRNA | Erlotinib | gCSI | pan-cancer | AAC | -0.018 | 0.7 |
mRNA | BI-2536 | GDSC1000 | pan-cancer | AAC | 0.018 | 0.7 |